Dermatofibrosarcoma Protuberans
📧 Sign up to get email alerts when something new happens for Dermatofibrosarcoma Protuberans.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-12-19FDA Approved: GLEEVEC — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for GLEEVEC (imatinib mesylate) from Novartis Pharmaceuticals Corporation, resulting in regulatory a…
-
FDA approval · 2007-09-13FDA Approved: GLEEVEC — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA supplemental application submitted for GLEEVEC (imatinib mesylate) by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2006-10-19FDA Approved: GLEEVEC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GLEEVEC (imatinib mesylate) submitted by Novartis Pharmaceuticals Corporation.